Professionals at REMS SW Ultrasound are taking the guesswork out of your bone health journey. REMS SW Ultrasound manager Jolene Davis stopped by New Mexico Living to talk about their technology that ...

Juanita (Rems) Myers, 85, of West Palm Beach, Florida and born in South Bend Indiana, passed away peacefully on 02/26/2026. After raising her family and retiring from Publix Supermarkets, she enjoyed ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Correspondence to Dr Jonathan Zipursky, Medicine, Sunnybrook Health Sciences Centre, Toronto, M4N 3M5, Canada; jonathan.zipursky{at}mail.utoronto.ca The first reproductive drug safety initiatives were ...

NEW YORK (PIX11) — Whether or not hundreds of thousands of New York City public housing residents and guests are safe when they ride the elevators in the sprawling housing system is at the center of ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.

It was only about a year ago that the biopharma industry hailed a decision by the Supreme Court to preserve access to mifepristone, a drug most commonly known for its paired use with another medicine ...

The update now reduces the frequency of liver function monitoring to every 3 months from the onset of treatment. The Food and Drug Administration (FDA) has updated the risk evaluation and mitigation ...

The following products no longer have a REMS requirement: Abecma; Breyanzi; Carvykti; Kymriah; Tecartus; and Yescarta. The Food and Drug Administration (FDA) has removed the Risk Evaluation and ...

The FDA has eliminated Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed autologous CAR-T cell immunotherapies, determining that the safety program is no ...

The FDA has officially eliminated clozapine's risk evaluation and mitigation strategy (REMS) program, with all REMS operations stopped as of June 13. The announcement comes several months after a ...